ArticleSleep & breathing = Schlaf & Atmung2026
Screening awareness of obstructive sleep apnea in children with down syndrome among primary care and pediatric sub-specialty clinicians by survey questionnaire.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the screening awareness of obstructive sleep apnea in children with Down syndrome among Primary Care and Pediatric Sub-Specialty Clinicians.
methodsA 15-question cross-sectional survey was conducted to determine the current awareness of OSA screening in DS children among primary care and pediatric subspecialty clinicians in the state of Kentucky. A Fisher's Exact test was performed to determine if the proportions of respondents differed significantly among different clinicians.
resultsA total of 97 responses were included. 73% of the clinicians specialized in pediatrics, 23% in family medicine, and 3% in ENT. Of the respondents, 50% were physician attendings, 27% were residents, and 23% were nurse practitioners or physician assistants. Although 94% of the respondents were aware that the prevalence of OSA in children with DS is higher than normally developing children, only 26% were aware of AAP guidelines and only 29.6% knew the age-specific threshold for screening regardless of symptoms. A significant difference existed between the type of clinicians who agreed that all DS children should undergo OSA screening regardless of symptoms: 85.4% of attending physicians, 57.7% of residents, and 81.8% of nurse practitioners (p < 0.03). In terms of specialty, 84% in pediatrics, 50% in medicine/pediatrics, and 59% in family medicine (p < 0.003).
conclusionsAAP screening guidelines for awareness of OSA in DS children vary among clinicians, their practice, and their specialty in Kentucky. Given the clinical implications of OSA, clinicians can utilize this study to identify knowledge gaps to address the barriers to screening guidelines education.
Indexed as
Identifiers
42319636What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.